Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology
Arizona-based, leading medical devices company, Confluent Medical Technologies, will be establishing a pilot manufacturing facility in Hyderabad.
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
Subscribe To Our Newsletter & Stay Updated